Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease

Suma P. Pyati, Rosita S. Pildes, Norman M. Jacobs, Rajam S. Ramamurthy, Tsu F. Yeh, Devyani S. Raval, Lawrence D. Lilien, P. Amma, William I. Metzger

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

We studied the effect of penicillin on early-onset Group B streptococcal disease over a 52-month period in neonates who were at high risk of infection. Shortly after birth, 1187 neonates weighing 2000 g or less had blood samples taken for cultures and were randomized into an early-treatment group (given intramuscular penicillin G within 60 minutes of birth) or a control group. The incidence of early-onset disease was 20 per 1000 live births (24 of 1187); the number of infants in the early-treatment group who had disease (10 of 589) was similar to that in the control group (14 of 598). The fatality rates were similar in both groups (6 of 10 vs. 8 of 14). Cultures from blood obtained within one hour of birth were positive in 21 of the 24 infants with disease; 22 of the 24 were symptomatic within four hours of birth. Thus, infection was well established before the first hour of postnatal life. At autopsy, gram-positive cocci were seen in lung sections of four infants in whom cultures of blood obtained after treatment had been sterile; this indicates that giving routine antibiotic therapy before culture samples are obtained can obscure bacteriologic diagnosis. We conclude that penicillin given at birth to neonates weighing 2000 g or less does not prevent early-onset streptococcal disease or reduce excess mortality associated with disease. (N Engl J Med 1983; 308:1383–9.) GROUP B streptococcal disease continues to be one of the most common infectious causes of morbidity and mortality in the neonatal period.1 2 3 4 The incidence of early-onset disease ranges from 1 to 4 per 1000 live births.5 The incidence of the disease and its fatality rate are higher in smaller premature infants than in larger infants.6 7 8 Efforts to prevent neonatal disease by eradicating the carrier state during pregnancy have been unsuccessful.9,10 A reduction of colonization in the neonate during the first three days of postnatal life can be achieved by intravenous administration of antibiotics during labor, but reduction of the incidence.

Original languageEnglish
Pages (from-to)1383-1389
Number of pages7
JournalNew England Journal of Medicine
Volume308
Issue number23
DOIs
Publication statusPublished - Jun 9 1983
Externally publishedYes

Fingerprint

Penicillins
Parturition
Newborn Infant
Incidence
Infant, Newborn, Diseases
Anti-Bacterial Agents
Carrier State
Gram-Positive Cocci
Control Groups
Penicillin G
Live Birth
Infant Mortality
Therapeutics
Infection
Premature Infants
Intravenous Administration
Autopsy
Morbidity
Pregnancy
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pyati, S. P., Pildes, R. S., Jacobs, N. M., Ramamurthy, R. S., Yeh, T. F., Raval, D. S., ... Metzger, W. I. (1983). Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease. New England Journal of Medicine, 308(23), 1383-1389. https://doi.org/10.1056/NEJM198306093082303

Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease. / Pyati, Suma P.; Pildes, Rosita S.; Jacobs, Norman M.; Ramamurthy, Rajam S.; Yeh, Tsu F.; Raval, Devyani S.; Lilien, Lawrence D.; Amma, P.; Metzger, William I.

In: New England Journal of Medicine, Vol. 308, No. 23, 09.06.1983, p. 1383-1389.

Research output: Contribution to journalArticle

Pyati, SP, Pildes, RS, Jacobs, NM, Ramamurthy, RS, Yeh, TF, Raval, DS, Lilien, LD, Amma, P & Metzger, WI 1983, 'Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease', New England Journal of Medicine, vol. 308, no. 23, pp. 1383-1389. https://doi.org/10.1056/NEJM198306093082303
Pyati, Suma P. ; Pildes, Rosita S. ; Jacobs, Norman M. ; Ramamurthy, Rajam S. ; Yeh, Tsu F. ; Raval, Devyani S. ; Lilien, Lawrence D. ; Amma, P. ; Metzger, William I. / Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease. In: New England Journal of Medicine. 1983 ; Vol. 308, No. 23. pp. 1383-1389.
@article{5312c35ec8c14d1ea965a838b26f3a33,
title = "Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease",
abstract = "We studied the effect of penicillin on early-onset Group B streptococcal disease over a 52-month period in neonates who were at high risk of infection. Shortly after birth, 1187 neonates weighing 2000 g or less had blood samples taken for cultures and were randomized into an early-treatment group (given intramuscular penicillin G within 60 minutes of birth) or a control group. The incidence of early-onset disease was 20 per 1000 live births (24 of 1187); the number of infants in the early-treatment group who had disease (10 of 589) was similar to that in the control group (14 of 598). The fatality rates were similar in both groups (6 of 10 vs. 8 of 14). Cultures from blood obtained within one hour of birth were positive in 21 of the 24 infants with disease; 22 of the 24 were symptomatic within four hours of birth. Thus, infection was well established before the first hour of postnatal life. At autopsy, gram-positive cocci were seen in lung sections of four infants in whom cultures of blood obtained after treatment had been sterile; this indicates that giving routine antibiotic therapy before culture samples are obtained can obscure bacteriologic diagnosis. We conclude that penicillin given at birth to neonates weighing 2000 g or less does not prevent early-onset streptococcal disease or reduce excess mortality associated with disease. (N Engl J Med 1983; 308:1383–9.) GROUP B streptococcal disease continues to be one of the most common infectious causes of morbidity and mortality in the neonatal period.1 2 3 4 The incidence of early-onset disease ranges from 1 to 4 per 1000 live births.5 The incidence of the disease and its fatality rate are higher in smaller premature infants than in larger infants.6 7 8 Efforts to prevent neonatal disease by eradicating the carrier state during pregnancy have been unsuccessful.9,10 A reduction of colonization in the neonate during the first three days of postnatal life can be achieved by intravenous administration of antibiotics during labor, but reduction of the incidence.",
author = "Pyati, {Suma P.} and Pildes, {Rosita S.} and Jacobs, {Norman M.} and Ramamurthy, {Rajam S.} and Yeh, {Tsu F.} and Raval, {Devyani S.} and Lilien, {Lawrence D.} and P. Amma and Metzger, {William I.}",
year = "1983",
month = "6",
day = "9",
doi = "10.1056/NEJM198306093082303",
language = "English",
volume = "308",
pages = "1383--1389",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "23",

}

TY - JOUR

T1 - Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease

AU - Pyati, Suma P.

AU - Pildes, Rosita S.

AU - Jacobs, Norman M.

AU - Ramamurthy, Rajam S.

AU - Yeh, Tsu F.

AU - Raval, Devyani S.

AU - Lilien, Lawrence D.

AU - Amma, P.

AU - Metzger, William I.

PY - 1983/6/9

Y1 - 1983/6/9

N2 - We studied the effect of penicillin on early-onset Group B streptococcal disease over a 52-month period in neonates who were at high risk of infection. Shortly after birth, 1187 neonates weighing 2000 g or less had blood samples taken for cultures and were randomized into an early-treatment group (given intramuscular penicillin G within 60 minutes of birth) or a control group. The incidence of early-onset disease was 20 per 1000 live births (24 of 1187); the number of infants in the early-treatment group who had disease (10 of 589) was similar to that in the control group (14 of 598). The fatality rates were similar in both groups (6 of 10 vs. 8 of 14). Cultures from blood obtained within one hour of birth were positive in 21 of the 24 infants with disease; 22 of the 24 were symptomatic within four hours of birth. Thus, infection was well established before the first hour of postnatal life. At autopsy, gram-positive cocci were seen in lung sections of four infants in whom cultures of blood obtained after treatment had been sterile; this indicates that giving routine antibiotic therapy before culture samples are obtained can obscure bacteriologic diagnosis. We conclude that penicillin given at birth to neonates weighing 2000 g or less does not prevent early-onset streptococcal disease or reduce excess mortality associated with disease. (N Engl J Med 1983; 308:1383–9.) GROUP B streptococcal disease continues to be one of the most common infectious causes of morbidity and mortality in the neonatal period.1 2 3 4 The incidence of early-onset disease ranges from 1 to 4 per 1000 live births.5 The incidence of the disease and its fatality rate are higher in smaller premature infants than in larger infants.6 7 8 Efforts to prevent neonatal disease by eradicating the carrier state during pregnancy have been unsuccessful.9,10 A reduction of colonization in the neonate during the first three days of postnatal life can be achieved by intravenous administration of antibiotics during labor, but reduction of the incidence.

AB - We studied the effect of penicillin on early-onset Group B streptococcal disease over a 52-month period in neonates who were at high risk of infection. Shortly after birth, 1187 neonates weighing 2000 g or less had blood samples taken for cultures and were randomized into an early-treatment group (given intramuscular penicillin G within 60 minutes of birth) or a control group. The incidence of early-onset disease was 20 per 1000 live births (24 of 1187); the number of infants in the early-treatment group who had disease (10 of 589) was similar to that in the control group (14 of 598). The fatality rates were similar in both groups (6 of 10 vs. 8 of 14). Cultures from blood obtained within one hour of birth were positive in 21 of the 24 infants with disease; 22 of the 24 were symptomatic within four hours of birth. Thus, infection was well established before the first hour of postnatal life. At autopsy, gram-positive cocci were seen in lung sections of four infants in whom cultures of blood obtained after treatment had been sterile; this indicates that giving routine antibiotic therapy before culture samples are obtained can obscure bacteriologic diagnosis. We conclude that penicillin given at birth to neonates weighing 2000 g or less does not prevent early-onset streptococcal disease or reduce excess mortality associated with disease. (N Engl J Med 1983; 308:1383–9.) GROUP B streptococcal disease continues to be one of the most common infectious causes of morbidity and mortality in the neonatal period.1 2 3 4 The incidence of early-onset disease ranges from 1 to 4 per 1000 live births.5 The incidence of the disease and its fatality rate are higher in smaller premature infants than in larger infants.6 7 8 Efforts to prevent neonatal disease by eradicating the carrier state during pregnancy have been unsuccessful.9,10 A reduction of colonization in the neonate during the first three days of postnatal life can be achieved by intravenous administration of antibiotics during labor, but reduction of the incidence.

UR - http://www.scopus.com/inward/record.url?scp=0020522147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020522147&partnerID=8YFLogxK

U2 - 10.1056/NEJM198306093082303

DO - 10.1056/NEJM198306093082303

M3 - Article

AN - SCOPUS:0020522147

VL - 308

SP - 1383

EP - 1389

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 23

ER -